<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20090311001760N48</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-09-17</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>Effect of ozonated water in scaling and root planing</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effects of ozonated water in non-surgical patients with chronic periodontitis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-08-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/41511</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization method: Simple randomization, randomization unit: individual, randomization tool: random number table, Blinding description: The first clinician assigns patients randomly to control and intervention groups.
The second clinician which is blind toward the treatment, evaluates the clinical parameters.
Scaling and root planing procedures are performed by a third clinician, who is blind regarding whether ozonated water or tap water is being used.
The follow-up visits are performed by the second clinician, too.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Chronic periodontitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group receives scaling and root planing (SRP) with ozonated-water. SRP includes full debridement of supragingival and subgingival plaque performed using a DTE D7 ultrasonic device (Made in IR. Iran. by Ozonsazan Pasargad corporation. SS8 Ozone generator). Full SRP is performed in two sessions of 40 minutes long each with a one-week interval in between the sessions. The DTE D7 ultrasonic device consists of a water tank filled with ozonated-water. Based on the half-life of ozone molecules in water, the water tanks are refilled with fresh ozonated-water after 20 minutes. The maximum safe concentration of ozone in water, based on previous studies, is 8 ppm, and its proper concentration in different dentistry treatments, including periodontal non-surgical ones, 1.5 ppm. After the procedure, patients are instructed properly to adhere to oral and dental hygiene. Each patient is followed up in four and eight weeks after the second treatment session. In each follow-up visit, the patient's clinical periodontal status is evaluated by periodontal pocket depth (PPD), clinical attachment level (CAL) and gingival index (GI). Intervention 2: Control group:  Patients in the control group receive scaling and root planing (SRP) with tap water. SRP included full debridement of supragingival and subgingival plaque performed using a DTE D7 ultrasonic device. Full SRP is performed in two sessions of 40 minutes long each with a one-week interval in between the sessions. The DTE D7 ultrasonic device with a water tank that is filled with tap water. To ensure that the methods that are used for patients of the control group are seemingly equivocal to those of the intervention group, the water tank is refilled with tap water after 20 minutes, too.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mojan Ghaforui</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, Ganj Afrouz St.</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47176-17745</zip>
        <telephone>+98 11 3219 9592</telephone>
        <email>ghafourimojan@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mohadese Yazdanpanah</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Dentistry, Babol University of Medical Sciences, Ganj Afrouz St.</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47176-47745</zip>
        <telephone>+98 11 3219 9592</telephone>
        <email>yazdanpanah.mohadese@com.yahoo</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Range age of 20-70 years
Mild to moderate chronic periodontitis
Patient with o’leary plaque index equal or less than 20</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Smoking
Pregnancy and Lactation
Any types of systemic disease like hyperthyroidism, severe anemia, severe myasthenia, acute alcohol poisoning, recent myocardial infarction, active bleeding, etc.
Patients who received surgical or non-surgical or antibiotic therapies over the past 6 months.
People who should not use ultrasonic devices, including people who has infectious diseases and immune deficiency, those at risk of respiratory diseases.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K05.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic periodontitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group receives scaling and root planing (SRP) with ozonated-water. SRP includes full debridement of supragingival and subgingival plaque performed using a DTE D7 ultrasonic device (Made in IR. Iran. by Ozonsazan Pasargad corporation. SS8 Ozone generator). Full SRP is performed in two sessions of 40 minutes long each with a one-week interval in between the sessions. The DTE D7 ultrasonic device consists of a water tank filled with ozonated-water. Based on the half-life of ozone molecules in water, the water tanks are refilled with fresh ozonated-water after 20 minutes. The maximum safe concentration of ozone in water, based on previous studies, is 8 ppm, and its proper concentration in different dentistry treatments, including periodontal non-surgical ones, 1.5 ppm. After the procedure, patients are instructed properly to adhere to oral and dental hygiene. Each patient is followed up in four and eight weeks after the second treatment session. In each follow-up visit, the patient's clinical periodontal status is evaluated by periodontal pocket depth (PPD), clinical attachment level (CAL) and gingival index (GI).</i_keyword>
      <i_keyword>Control group:  Patients in the control group receive scaling and root planing (SRP) with tap water. SRP included full debridement of supragingival and subgingival plaque performed using a DTE D7 ultrasonic device. Full SRP is performed in two sessions of 40 minutes long each with a one-week interval in between the sessions. The DTE D7 ultrasonic device with a water tank that is filled with tap water. To ensure that the methods that are used for patients of the control group are seemingly equivocal to those of the intervention group, the water tank is refilled with tap water after 20 minutes, too.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Periodontal pocket depth. Timepoint: baseline, 4 and 8 week after scaling and root planing (SRP). Method of measurement: William's periodontal probe.</prim_outcome>
      <prim_outcome>Clinical attachment loss. Timepoint: baseline, 4 and 8 week after SRP. Method of measurement: William's periodontal probe.</prim_outcome>
      <prim_outcome>Gingival index. Timepoint: baseline, 4 and 8 week after SRP. Method of measurement: William's periodontal probe.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-04-23</approval_date>
        <contact_name>Ethics Committee of Babol University of Medical Sciences</contact_name>
        <contact_address>Babol University of Medical Sciences, Ganj Afrouz St. Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
